MCID: INC029
MIFTS: 25

Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1

Categories: Genetic diseases

Aliases & Classifications for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

MalaCards integrated aliases for Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:

Name: Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1 57 75
Inclusion Body Myopathy with Early-Onset Paget Disease and Frontotemporal Dementia 75 73
Lower Motor Neuron Degeneration with Paget-Like Bone Disease 57 75
Pagetoid Amyotrophic Lateral Sclerosis 57 75
Pagetoid Neuroskeletal Syndrome 57 75
Ibmpfd1 57 75
Inclusion Body Myopathy with Early-Onset Paget Disease and Frontotemporal Dementia 1 57
Muscular Dystrophy, Limb-Girdle, with Paget Disease of Bone 57
Limb-Girdle Muscular Dystrophy with Paget Disease of Bone 75
Multisystem Proteinopathy 1; Msp1 57
Multisystem Proteinopathy 1 57
Msp1 57

Characteristics:

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
mean age at onset of muscle disease is 42 years (range 24-61)
mean age at onset of bone disease is 40 years (range 23-65)
mean age at onset of dementia is 57 years
many patients become wheelchair-bound
incomplete penetrance of the 3 main clinical signs, myopathy, dementia, and paget disease


HPO:

32
inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1:
Inheritance autosomal dominant inheritance


Classifications:



Summaries for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

OMIM : 57 IBMPFD is an autosomal dominant disorder characterized by incomplete penetrance of 3 main features: disabling muscle weakness (in 90%), osteolytic bone lesions consistent with Paget disease (in 51%), and frontotemporal dementia (in 32%). Muscle weakness is an isolated symptom in about 30% of patients and the presenting symptom in greater than half of patients, suggesting that IBMPFD may commonly be seen in a neuromuscular clinic without its other syndromic features (review by Weihl et al., 2009). (167320)

MalaCards based summary : Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1, also known as inclusion body myopathy with early-onset paget disease and frontotemporal dementia, is related to inclusion body myopathy with early-onset paget disease and frontotemporal dementia and malaria, and has symptoms including back pain and hip pain. An important gene associated with Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1 is VCP (Valosin Containing Protein). Affiliated tissues include bone, and related phenotypes are gait disturbance and dysphasia

UniProtKB/Swiss-Prot : 75 Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1: An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.

Related Diseases for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Diseases related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 inclusion body myopathy with early-onset paget disease and frontotemporal dementia 11.5
2 malaria 10.4
3 plasmodium falciparum malaria 10.2
4 esophageal cancer 9.9
5 lung cancer 9.9
6 esophagitis 9.9
7 gallbladder cancer 9.9

Graphical network of the top 20 diseases related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:



Diseases related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1

Symptoms & Phenotypes for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Symptoms via clinical synopsis from OMIM:

57
Neurologic Central Nervous System:
dystonia
gait abnormalities
frontotemporal dementia (in 30% of patients)
expressive dysphasia
dystrophic neurites
more
Muscle Soft Tissue:
proximal muscle weakness
rimmed vacuoles
distal muscle atrophy
muscle weakness (in 90% of patients)
shoulder weakness and atrophy
more
Laboratory Abnormalities:
increased serum creatine kinase
increased serum bone-specific alkaline phosphatase

Head And Neck Face:
facial weakness (less common)

Skeletal Spine:
back pain
lumbar lordosis

Skeletal Pelvis:
hip pain

Chest Ribs Sternum Clavicles And Scapulae:
winged scapulae

Skeletal:
paget disease (in 50% of patients)


Clinical features from OMIM:

167320

Human phenotypes related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:

32 (show all 27)
# Description HPO Frequency HPO Source Accession
1 gait disturbance 32 HP:0001288
2 dysphasia 32 HP:0002357
3 facial palsy 32 occasional (7.5%) HP:0010628
4 myopathy 32 HP:0003198
5 elevated serum creatine phosphokinase 32 HP:0003236
6 dystonia 32 HP:0001332
7 scapular winging 32 HP:0003691
8 amyotrophic lateral sclerosis 32 HP:0007354
9 dementia 32 HP:0000726
10 back pain 32 HP:0003418
11 abnormality of pelvic girdle bone morphology 32 HP:0002644
12 limb muscle weakness 32 HP:0003690
13 proximal muscle weakness 32 HP:0003701
14 rimmed vacuoles 32 HP:0003805
15 lumbar hyperlordosis 32 HP:0002938
16 distal amyotrophy 32 HP:0003693
17 frontotemporal dementia 32 HP:0002145
18 difficulty climbing stairs 32 HP:0003551
19 pelvic girdle muscle weakness 32 HP:0003749
20 shoulder girdle muscle weakness 32 HP:0003547
21 frontal cortical atrophy 32 HP:0006913
22 elevated alkaline phosphatase of bone origin 32 HP:0010639
23 shoulder girdle muscle atrophy 32 HP:0003724
24 hip pain 32 HP:0030838
25 temporal cortical atrophy 32 HP:0007112
26 pelvic girdle muscle atrophy 32 HP:0008988
27 pelvic girdle amyotrophy 32 HP:0008946

UMLS symptoms related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:


back pain, hip pain

Drugs & Therapeutics for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Search Clinical Trials , NIH Clinical Center for Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1

Genetic Tests for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Anatomical Context for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

MalaCards organs/tissues related to Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:

41
Bone

Publications for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Variations for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

UniProtKB/Swiss-Prot genetic disease variations for Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:

75
# Symbol AA change Variation ID SNP ID
1 VCP p.Arg95Gly VAR_033016 rs121909332
2 VCP p.Arg155Cys VAR_033017 rs121909330
3 VCP p.Arg155His VAR_033018 rs121909329
4 VCP p.Arg155Pro VAR_033019 rs121909329
5 VCP p.Arg159His VAR_033020 rs121909335
6 VCP p.Arg191Gln VAR_033021 rs121909334
7 VCP p.Ala232Glu VAR_033022 rs121909331
8 VCP p.Arg155Ser VAR_076466
9 VCP p.Leu198Trp VAR_076468
10 VCP p.Arg155Leu VAR_078910

ClinVar genetic disease variations for Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1:

6
(show top 50) (show all 78)
# Gene Variation Type Significance SNP ID Assembly Location
1 VCP NM_007126.4(VCP): c.464G> A (p.Arg155His) single nucleotide variant Pathogenic rs121909329 GRCh37 Chromosome 9, 35065360: 35065360
2 VCP NM_007126.4(VCP): c.464G> A (p.Arg155His) single nucleotide variant Pathogenic rs121909329 GRCh38 Chromosome 9, 35065363: 35065363
3 VCP NM_007126.4(VCP): c.463C> T (p.Arg155Cys) single nucleotide variant Pathogenic rs121909330 GRCh37 Chromosome 9, 35065361: 35065361
4 VCP NM_007126.4(VCP): c.463C> T (p.Arg155Cys) single nucleotide variant Pathogenic rs121909330 GRCh38 Chromosome 9, 35065364: 35065364
5 VCP NM_007126.4(VCP): c.695C> A (p.Ala232Glu) single nucleotide variant Pathogenic rs121909331 GRCh37 Chromosome 9, 35064164: 35064164
6 VCP NM_007126.4(VCP): c.695C> A (p.Ala232Glu) single nucleotide variant Pathogenic rs121909331 GRCh38 Chromosome 9, 35064167: 35064167
7 VCP NM_007126.4(VCP): c.283C> G (p.Arg95Gly) single nucleotide variant Pathogenic rs121909332 GRCh37 Chromosome 9, 35067907: 35067907
8 VCP NM_007126.4(VCP): c.283C> G (p.Arg95Gly) single nucleotide variant Pathogenic rs121909332 GRCh38 Chromosome 9, 35067910: 35067910
9 VCP NM_007126.4(VCP): c.464G> C (p.Arg155Pro) single nucleotide variant Pathogenic rs121909329 GRCh37 Chromosome 9, 35065360: 35065360
10 VCP NM_007126.4(VCP): c.464G> C (p.Arg155Pro) single nucleotide variant Pathogenic rs121909329 GRCh38 Chromosome 9, 35065363: 35065363
11 VCP NM_007126.4(VCP): c.572G> A (p.Arg191Gln) single nucleotide variant Pathogenic/Likely pathogenic rs121909334 GRCh37 Chromosome 9, 35065252: 35065252
12 VCP NM_007126.4(VCP): c.572G> A (p.Arg191Gln) single nucleotide variant Pathogenic/Likely pathogenic rs121909334 GRCh38 Chromosome 9, 35065255: 35065255
13 VCP NM_007126.4(VCP): c.476G> A (p.Arg159His) single nucleotide variant Pathogenic rs121909335 GRCh37 Chromosome 9, 35065348: 35065348
14 VCP NM_007126.4(VCP): c.476G> A (p.Arg159His) single nucleotide variant Pathogenic rs121909335 GRCh38 Chromosome 9, 35065351: 35065351
15 VCP NM_007126.4(VCP): c.2214A> G (p.Glu738=) single nucleotide variant Benign/Likely benign rs374391034 GRCh37 Chromosome 9, 35057474: 35057474
16 VCP NM_007126.4(VCP): c.2214A> G (p.Glu738=) single nucleotide variant Benign/Likely benign rs374391034 GRCh38 Chromosome 9, 35057477: 35057477
17 VCP NM_007126.3(VCP): c.2406T> C (p.Asp802=) single nucleotide variant Conflicting interpretations of pathogenicity rs145508640 GRCh37 Chromosome 9, 35057129: 35057129
18 VCP NM_007126.3(VCP): c.2406T> C (p.Asp802=) single nucleotide variant Conflicting interpretations of pathogenicity rs145508640 GRCh38 Chromosome 9, 35057132: 35057132
19 VCP NM_007126.4(VCP): c.463C> G (p.Arg155Gly) single nucleotide variant Pathogenic/Likely pathogenic rs121909330 GRCh37 Chromosome 9, 35065361: 35065361
20 VCP NM_007126.4(VCP): c.463C> G (p.Arg155Gly) single nucleotide variant Pathogenic/Likely pathogenic rs121909330 GRCh38 Chromosome 9, 35065364: 35065364
21 VCP NM_007126.3(VCP): c.271A> T (p.Asn91Tyr) single nucleotide variant Likely pathogenic rs863225291 GRCh38 Chromosome 9, 35067922: 35067922
22 VCP NM_007126.3(VCP): c.271A> T (p.Asn91Tyr) single nucleotide variant Likely pathogenic rs863225291 GRCh37 Chromosome 9, 35067919: 35067919
23 VCP NM_007126.4(VCP): c.1704A> G (p.Gln568=) single nucleotide variant Benign/Likely benign rs142577424 GRCh37 Chromosome 9, 35059790: 35059790
24 VCP NM_007126.4(VCP): c.1704A> G (p.Gln568=) single nucleotide variant Benign/Likely benign rs142577424 GRCh38 Chromosome 9, 35059793: 35059793
25 VCP NM_007126.3(VCP): c.1082-18_1082-8dupTTGTGTACTGT duplication Benign rs11272867 GRCh37 Chromosome 9, 35061694: 35061704
26 VCP NM_007126.3(VCP): c.1082-18_1082-8dupTTGTGTACTGT duplication Benign rs11272867 GRCh38 Chromosome 9, 35061697: 35061707
27 VCP NM_007126.3(VCP): c.1584C> T (p.Ala528=) single nucleotide variant Conflicting interpretations of pathogenicity rs147623367 GRCh37 Chromosome 9, 35060421: 35060421
28 VCP NM_007126.3(VCP): c.1584C> T (p.Ala528=) single nucleotide variant Conflicting interpretations of pathogenicity rs147623367 GRCh38 Chromosome 9, 35060424: 35060424
29 VCP NM_007126.3(VCP): c.79A> G (p.Ile27Val) single nucleotide variant Benign rs140913250 GRCh37 Chromosome 9, 35068298: 35068298
30 VCP NM_007126.3(VCP): c.79A> G (p.Ile27Val) single nucleotide variant Benign rs140913250 GRCh38 Chromosome 9, 35068301: 35068301
31 VCP NM_007126.4(VCP): c.18-5T> C single nucleotide variant Benign/Likely benign rs114256093 GRCh37 Chromosome 9, 35068364: 35068364
32 VCP NM_007126.4(VCP): c.18-5T> C single nucleotide variant Benign/Likely benign rs114256093 GRCh38 Chromosome 9, 35068367: 35068367
33 VCP NM_007126.4(VCP): c.1092C> T (p.Asp364=) single nucleotide variant Benign/Likely benign rs61752947 GRCh37 Chromosome 9, 35061676: 35061676
34 VCP NM_007126.4(VCP): c.1092C> T (p.Asp364=) single nucleotide variant Benign/Likely benign rs61752947 GRCh38 Chromosome 9, 35061679: 35061679
35 VCP NM_007126.4(VCP): c.927C> T (p.Ile309=) single nucleotide variant Benign/Likely benign rs34097935 GRCh38 Chromosome 9, 35062235: 35062235
36 VCP NM_007126.4(VCP): c.927C> T (p.Ile309=) single nucleotide variant Benign/Likely benign rs34097935 GRCh37 Chromosome 9, 35062232: 35062232
37 VCP NM_007126.4(VCP): c.278G> A (p.Arg93His) single nucleotide variant Conflicting interpretations of pathogenicity rs779959657 GRCh37 Chromosome 9, 35067912: 35067912
38 VCP NM_007126.4(VCP): c.278G> A (p.Arg93His) single nucleotide variant Conflicting interpretations of pathogenicity rs779959657 GRCh38 Chromosome 9, 35067915: 35067915
39 VCP NM_007126.4(VCP): c.2412G> A (p.Leu804=) single nucleotide variant Likely benign rs757712897 GRCh38 Chromosome 9, 35057126: 35057126
40 VCP NM_007126.4(VCP): c.2412G> A (p.Leu804=) single nucleotide variant Likely benign rs757712897 GRCh37 Chromosome 9, 35057123: 35057123
41 VCP NM_007126.4(VCP): c.426G> A (p.Ala142=) single nucleotide variant Conflicting interpretations of pathogenicity rs577812326 GRCh38 Chromosome 9, 35066694: 35066694
42 VCP NM_007126.4(VCP): c.426G> A (p.Ala142=) single nucleotide variant Conflicting interpretations of pathogenicity rs577812326 GRCh37 Chromosome 9, 35066691: 35066691
43 VCP NM_007126.4(VCP): c.576+10C> G single nucleotide variant Likely benign rs757728490 GRCh37 Chromosome 9, 35065238: 35065238
44 VCP NM_007126.4(VCP): c.576+10C> G single nucleotide variant Likely benign rs757728490 GRCh38 Chromosome 9, 35065241: 35065241
45 VCP NM_007126.4(VCP): c.1696-7C> T single nucleotide variant Likely benign GRCh37 Chromosome 9, 35059805: 35059805
46 VCP NM_007126.4(VCP): c.1696-7C> T single nucleotide variant Likely benign GRCh38 Chromosome 9, 35059808: 35059808
47 VCP NM_007126.4(VCP): c.1082-9G> T single nucleotide variant Benign rs12349922 GRCh37 Chromosome 9, 35061695: 35061695
48 VCP NM_007126.4(VCP): c.1082-9G> T single nucleotide variant Benign rs12349922 GRCh38 Chromosome 9, 35061698: 35061698
49 VCP NM_007126.4(VCP): c.1017A> G (p.Ala339=) single nucleotide variant Likely benign rs565534943 GRCh37 Chromosome 9, 35062064: 35062064
50 VCP NM_007126.4(VCP): c.1017A> G (p.Ala339=) single nucleotide variant Likely benign rs565534943 GRCh38 Chromosome 9, 35062067: 35062067

Expression for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Search GEO for disease gene expression data for Inclusion Body Myopathy with Early-Onset Paget Disease with or Without Frontotemporal Dementia 1.

Pathways for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

GO Terms for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

Sources for Inclusion Body Myopathy with Early-Onset Paget Disease with or...

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....